Compounds > chlorpromazine

chlorpromazine and hydromorphone

chlorpromazine has been researched along with hydromorphone in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hannam, RV; Shuster, L1
Juvara, I; Radulesco, D1
CHU, J1

Reviews

2 review(s) available for chlorpromazine and hydromorphone

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for chlorpromazine and hydromorphone

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Changes in morphine- and chlorpromazine-N-demethylase during the development of tolerance to chlorpromazine in mice.
    Canadian journal of biochemistry, 1965, Volume: 43, Issue:7

    Topics: Animals; Chlorpromazine; Drug Tolerance; Enzymes; Ethionine; Hydromorphone; In Vitro Techniques; Liver; Mice; Microsomes

1965
[Modifications of the contractility of the sphincter of Oddi under the influence of central analgesics].
    Revue internationale d'hepatologie, 1967, Volume: 17, Issue:1

    Topics: Ampulla of Vater; Amyl Nitrite; Atropine; Chlorpromazine; Cholecystectomy; Humans; Hydromorphone; Meperidine; Methadone; Procaine

1967
Effect of chlorpromazine on addiction; a preliminary report of two cases of dilaudid, morphine and codeine addictions.
    The West Virginia medical journal, 1956, Volume: 52, Issue:1

    Topics: Chlorpromazine; Codeine; Humans; Hydromorphone; Morphine; Morphine Dependence; Substance-Related Disorders

1956